| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [A. R. K., J. H. C., R. E. P.]; Department of Epidemiology, University of Washington, Seattle, Washington 98195 [A. R. K., J. L. S., J. H. C., R. E. P.]; and Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [J. L. S., K. W.]
This population-based, case-control study in King County, Washington examined supplement use in 697 incident prostate cancer cases (ages 4064) identified from the Puget Sound Surveillance, Epidemiology and End Results program registry and 666 controls recruited from the same overall population using random-digit dialing sampling. Participants reported their frequency of use of three types of multivitamins and single supplements of vitamins A, C, and E, calcium, iron, and zinc over the 2 years before diagnosis. Logistic regression analyses controlled for age, race, education, family history of prostate cancer, body mass index, number of prostate-specific antigen tests in the previous 5 years, and dietary fat intake. Adjusted odds ratios (95% confidence limits) for the contrast of
7/week versus no use were as follows: multivitamins, 0.96 (0.73, 1.26); vitamin A, 0.59 (0.32, 1.06); vitamin C, 0.77 (0.57, 1.04); vitamin E, 0.76 (0.54, 1.08); calcium, 1.04 (0.61, 1.78); iron, 0.50 (0.13, 1.76); and zinc, 0.55 (0.30, 1.00). Odds ratios differed little when cases were stratified by stage of disease at diagnosis or by histopathological grade. There were significant dose-response effects for zinc and ordered dose-response trends for vitamins C and E. Overall, these results suggest that multivitamin use is not associated with prostate cancer risk, but use of individual supplements of zinc, vitamin C, and vitamin E may be protective. Further study is needed to investigate the direct role of these dietary supplements, as well as the role of lifestyle variables associated with supplement use, on prostate cancer risk.
This article has been cited by other articles:
![]() |
M. Yan, Y. Song, C. P. Wong, K. Hardin, and E. Ho Zinc Deficiency Alters DNA Damage Response Genes in Normal Human Prostate Epithelial Cells J. Nutr., April 1, 2008; 138(4): 667 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wright, S. J. Weinstein, K. A. Lawson, D. Albanes, A. F. Subar, L. B. Dixon, T. Mouw, A. Schatzkin, and M. F. Leitzmann Supplemental and Dietary Vitamin E Intakes and Risk of Prostate Cancer in a Large Prospective Study Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1128 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Weinstein, M. E. Wright, K. A. Lawson, K. Snyder, S. Mannisto, P. R. Taylor, J. Virtamo, and D. Albanes Serum and Dietary Vitamin E in Relation to Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1253 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Lawson, M. E. Wright, A. Subar, T. Mouw, A. Hollenbeck, A. Schatzkin, and M. F. Leitzmann Multivitamin Use and Risk of Prostate Cancer in the National Institutes of Health-AARP Diet and Health Study J Natl Cancer Inst, May 16, 2007; 99(10): 754 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Chen and P. G. Wells Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E Carcinogenesis, July 1, 2006; 27(7): 1358 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Park, S. P. Murphy, L. R. Wilkens, J. F. Yamamoto, and L. N. Kolonel Allowing for Variations in Multivitamin Supplement Composition Improves Nutrient Intake Estimates for Epidemiologic Studies J. Nutr., May 1, 2006; 136(5): 1359 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Baron, M. Beach, K. Wallace, M. V. Grau, R. S. Sandler, J. S. Mandel, D. Heber, and E. R. Greenberg Risk of Prostate Cancer in a Randomized Clinical Trial of Calcium Supplementation Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 586 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippman, P. J. Goodman, E. A. Klein, H. L. Parnes, I. M. Thompson, A. R. Kristal, R. M. Santella, J. L. Probstfield, C. M. Moinpour, D. Albanes, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT) J Natl Cancer Inst, January 19, 2005; 97(2): 94 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Jarrard Does Zinc Supplementation Increase the Risk of Prostate Cancer? Arch Ophthalmol, January 1, 2005; 123(1): 102 - 103. [Full Text] [PDF] |
||||
![]() |
E. T. Chang, M. Hedelin, H.-O. Adami, H. Gronberg, and K. A. Balter Re: Zinc Supplement Use and Risk of Prostate Cancer J Natl Cancer Inst, July 21, 2004; 96(14): 1108 - 1108. [Full Text] [PDF] |
||||
![]() |
C. Rodriguez, E. J. Jacobs, A. M. Mondul, E. E. Calle, M. L. McCullough, and M. J. Thun Vitamin E Supplements and Risk of Prostate Cancer in U.S. Men Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 378 - 382. [Abstract] [Full Text] |
||||
![]() |
L. C. Costello, R. B. Franklin, P. Feng, and M. Tan Re: Zinc Supplement Use and Risk of Prostate Cancer J Natl Cancer Inst, February 4, 2004; 96(3): 239 - 240. [Full Text] [PDF] |
||||
![]() |
S. Wilkinson and G. W. Chodak Critical Review of Complementary Therapies for Prostate Cancer J. Clin. Oncol., June 1, 2003; 21(11): 2199 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Huang, A. J. Alberg, E. P. Norkus, S. C. Hoffman, G. W. Comstock, and K. J. Helzlsouer Prospective Study of Antioxidant Micronutrients in the Blood and the Risk of Developing Prostate Cancer Am. J. Epidemiol., February 15, 2003; 157(4): 335 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Kristal, J. H. Cohen, P. Qu, and J. L. Stanford Associations of Energy, Fat, Calcium, and Vitamin D with Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 719 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. COHEN Nutrition and Prostate Cancer: A Review Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 148 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Chan, M. J Stampfer, J. Ma, P. H Gann, J M. Gaziano, and E. L Giovannucci Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study Am. J. Clinical Nutrition, October 1, 2001; 74(4): 549 - 554. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |